Join the club for FREE to access the whole archive and other member benefits.

3D printed lung scaffold might be ready for clinical trials within five years

It can be personalised with patients' own cells and printed in three weeks


Key points from article :

United Therapeutics and 3D Systems has showcased 3D printed human lung scaffold at the recent LIFE ITSELF conference.

They are working together for several years on the development of their Print to Perfusion process.

Planning to cellularize the scaffold with a patient’s own stem cells and are now demonstrating gas exchange in animal models.

More than 2,500 patients receiving a lung transplant in the US during 2021, and 1,075 currently on the lung transplant list.

"[] We hope to have these personalized, manufactured lungs cleared for human trials in under five years." said Dr. Martine Rothblatt, United Therapeutics’ Chairperson and CEO.

The firm has acquired 3D bioprinter developer Allevi, and bought volumetric Biotechnologies for $400 million.

It claims a record 44 trillion voxels that lay out 4,000 km of pulmonary capillaries and 200 million alveoli.

"These lung designs can be printed in as little as three weeks-" said 3D Systems Executive Vice President and CTO Chuck Hull.

Mentioned in this article:

Click on resource name for more details.

3D Systems

Company that engineers, manufactures and sells 3D printers, 3D printing materials, 3D scanners, and offers a 3D printing service.

Chuck Hull

3D Systems Executive Vice President and Chief technical Officer, Father of 3D printing

Martine Rothblatt

United Therapeutics Founder Chairperson, Chief Executive Officer and Director

United Therapeutics

United Therapeutics Corporation is a biotechnology company


Biomaterials and biofabrication company.

Topics mentioned on this page:
3D Printing, Respiratory Disease